IBRDC1 Antibodies

Santa Cruz Biotechnology delivers a wide array of IBRDC1 monoclonal antibodies for research applications. IBRDC1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IBRDC1, or Interferon-β Receptor-Dependent Cytokine Inducer 1, plays a crucial role in the immune response by mediating the effects of interferon signaling. IBRDC1 is essential for the regulation of inflammatory processes and has implications in various diseases, including autoimmune disorders and cancer. Understanding IBRDC1 function is vital for advancing therapeutic strategies and improving patient outcomes. Researchers can utilize IBRDC1 monoclonal antibodies to explore cellular pathways and molecular interactions. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization and quantification of IBRDC1. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by facilitating discoveries in immunology and disease research.